CARIBOU BIOSCIENCES INC. - COMMON STOCK

Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors

11 مايو 2022 15:00:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates

09 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conference

03 مايو 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Share CB-010 Initial Clinical Data at the Upcoming European Hematology Association (EHA) 2022 Hybrid Congress

25 أبريل 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

08 أبريل 2022 12:07:17 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

21 مارس 2022 15:02:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting

08 مارس 2022 19:19:17 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

07 مارس 2022 15:10:57 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference

07 فبراير 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer

18 يناير 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

04 يناير 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

17 نوفمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results

09 نوفمبر 2021 15:05:03 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer

08 نوفمبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

20 أكتوبر 2021 15:00:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors

29 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

27 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Announces Publication of Data Demonstrating High Specificity Genome Editing with its Proprietary chRDNA Technology

02 سبتمبر 2021 15:05:01 بحسب Nasdaq GlobeNewswire

Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference

01 سبتمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire

Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors

25 أغسطس 2021 15:00:00 بحسب Nasdaq GlobeNewswire